9 Pharmaceuticals Stocks to Buy Now

Advertisement

The grades of 9 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

Allergan plc (AGN) shows solid improvement this week. The company’s rating rises from a C to a B. Allergan plc is a healthcare company focused on developing and commercializing pharmaceuticals, biologics, and medical devices. The company also gets A’s in sales growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of AGN stock.

This week, Shire PLC Sponsored ADR’s (SHPG) ratings are up from a C last week to a B. Shire PLC Sponsored ADR a biopharmaceutical company, researches, develops, manufactures, sells, and distributes pharmaceutical products. The company also gets A’s in operating margin growth, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of SHPG stock.

Novo Nordisk A/S Sponsored ADR Class B (NVO) improves from a B to a A rating this week. Novo Nordisk A/S Sponsored ADR Class B develops, produces, and markets pharmaceutical products. The company also gets A’s in sales growth, earnings growth, and return on equity. For more information, get Portfolio Grader’s complete analysis of NVO stock.

Sanofi Sponsored ADR (SNY) is seeing ratings go up from a C last week to a B this week. Sanofi Sponsored ADR is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The company also gets A’s in earnings growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of SNY stock.

The rating of Intersect ENT Inc (XENT) moves up this week, rising from a C to a B. The company also gets A’s in sales growth. For more information, get Portfolio Grader’s complete analysis of XENT stock.

This is a strong week for Cynapsus Therapeutics Inc. (CYNA). The company’s rating climbs to B from the previous week’s C. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of CYNA stock.

Zogenix, Inc. (ZGNX) gets a higher grade this week, advancing from a C last week to a B. Zogenix, Inc. is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. For more information, get Portfolio Grader’s complete analysis of ZGNX stock.

Assembly Biosciences, Inc.’s (ASMB) ratings are looking better this week, moving up to a B from last week’s C. For more information, get Portfolio Grader’s complete analysis of ASMB stock.

Alcobra Ltd. (ADHD) earns a A this week, jumping up from last week’s grade of B. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of ADHD stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/11/9-pharmaceuticals-stocks-to-buy-now/.

©2024 InvestorPlace Media, LLC